Seroprevalence of hepatitis A among individuals with chronic hepatitis B infection in Isfahan Province, Iran
暂无分享,去创建一个
B. Ataei | M. Yaran | Z. Nokhodian | B. Vakili | P. Shoaei | S. Najafi | L. Z. Nejad
[1] EASL clinical practice guidelines: Management of chronic hepatitis B virus infection. , 2012, Journal of hepatology.
[2] Seonwoo Kim,et al. Seroprevalence of anti-HAV among patients with chronic viral liver disease. , 2011, World journal of gastroenterology.
[3] W. Shin,et al. Prevalence of IgG anti-HAV in patients with chronic hepatitis B and in the general healthy population in Korea , 2010, The Korean journal of hepatology.
[4] K. Jacobsen,et al. Hepatitis A virus seroprevalence by age and world region, 1990 and 2005. , 2010, Vaccine.
[5] O. Kwon,et al. Factors influencing the severity of acute viral hepatitis A , 2010, The Korean journal of hepatology.
[6] R. Malekzadeh,et al. Seroprevalence and risk factors of hepatitis A virus infection in Iran: a population based study. , 2010, Archives of Iranian medicine.
[7] R. Majdzadeh,et al. Prevalence of chronic hepatitis B infection in Iran: a review article , 2009, Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences.
[8] T. Tamimi,et al. Hepatitis B virus infection : Understanding its epidemiology, course, and diagnosis , 2008 .
[9] S. Farhang,et al. Prevalence of hepatitis A in Iranian patients with chronic liver disease. , 2008 .
[10] Ali Bijani,et al. Prevalence of hepatitis A IgG in individuals with chronic hepatitis B infection in Babol. , 2007, Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit.
[11] J. Seo,et al. Changes in the age-specific prevalence of hepatitis A virus antibodies: a 10-year cohort study in Jinju, South Korea. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.